Beung‐Chul Ahn
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 19
- Lung Cancer Diagnosis and Treatment 3
- Oncology 22
- Cancer Immunotherapy and Biomarkers 9
- Lung Cancer Research Studies 9
- Pancreatic and Hepatic Oncology Research 3
- Co-authors
- Min Hee Hong (25 shared papers)Byoung Chul Cho (22 shared papers)Hye Ryun Kim (16 shared papers)Hyo Sup Shim (6 shared papers)Kyoung‐Ho Pyo (12 shared papers)Hong In Yoon (4 shared papers)Sung Yong Park (2 shared papers)Eui‐Cheol Shin (2 shared papers)
- Journals
- Cancers (5 papers)Cancer Research (4 papers)Journal of Thoracic Oncology (4 papers)Annals of Oncology (4 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- South KoreaUnited StatesSweden
In The Last Decade
Beung‐Chul Ahn
35 papers receiving 634 citations
Peers
Comparison fields: 5 of 40
- Oncology 407
- Pulmonary and Respiratory Medicine 268
- Immunology 87
- Cancer Research 54
- Otorhinolaryngology 9
Countries citing papers authored by Beung‐Chul Ahn
This map shows the geographic impact of Beung‐Chul Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beung‐Chul Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beung‐Chul Ahn more than expected).
Fields of papers citing papers by Beung‐Chul Ahn
This network shows the impact of papers produced by Beung‐Chul Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beung‐Chul Ahn. The network helps show where Beung‐Chul Ahn may publish in the future.
Co-authors
The 25 scholars most cited alongside Beung‐Chul Ahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 203 | |
| 2 | 2018 | 86 | |
| 3 | 2019 | 75 | |
| 4 | 2020 | 35 | |
| 5 | 2021 | 32 | |
| 6 | 2019 | 28 | |
| 7 | 2019 | 28 | |
| 8 | 2019 | 17 | |
| 9 | 2022 | 17 | |
| 10 | 2021 | 16 | |
| 11 | 2023 | 14 | |
| 12 | 2022 | 12 | |
| 13 | 2021 | 10 | |
| 14 | 2024 | 8 | |
| 15 | 2021 | 8 | |
| 16 | 2021 | 6 | |
| 17 | 2021 | 6 | |
| 18 | 2023 | 4 | |
| 19 | 2024 | 4 | |
| 20 | 2021 | 4 |
About Beung‐Chul Ahn
Beung‐Chul Ahn is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 41 papers that have together received 637 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (19 papers), Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Research Studies (9 papers), Cancer Genomics and Diagnostics (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Radiomics and Machine Learning in Medical Imaging (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Esophageal Cancer Research and Treatment (3 papers). The work is most often cited by research in Oncology (407 citations), Pulmonary and Respiratory Medicine (268 citations), Immunology (87 citations), Cancer Research (54 citations) and Otorhinolaryngology (9 citations). Beung‐Chul Ahn has collaborated with scholars based in South Korea, United States and Sweden. Frequent co-authors include Min Hee Hong, Byoung Chul Cho, Hye Ryun Kim, Hyo Sup Shim, Kyoung‐Ho Pyo, Hong In Yoon, Sung Yong Park, Eui‐Cheol Shin, Seong Jin Choi and Sun Min Lim. Their work appears in journals such as Cancers, Cancer Research, Journal of Thoracic Oncology, Annals of Oncology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.